Crowley John F 4
4 · AMICUS THERAPEUTICS, INC. · Filed Jan 18, 2024
Insider Transaction Report
Form 4
Crowley John F
DirectorPresident & CEO
Transactions
- Sale
Common Stock
2024-01-16$12.78/sh−31,614$404,106→ 837,779 total
Holdings
- 64,895(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $12.68 to $12.92 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.